Biology Reference
In-Depth Information
101. Delaunois A, Gustin P, Ansay M. Effects of capsaicin on the endothelial permeability in
isolated and perfused rabbit lungs. Fundam Clin Pharmacol 1993;7:81-91.
102. Germonpré PR, Joos GF, Mekeirele K, Pauwels RA. Role of the 5-HT receptor in neuro-
genic inflammation in Fisher 344 rat airways. Eur J Pharmacol 1997;324:249-55.
103. Van Rensen EL, Hiemstra PS, Rabe KF, Sterk PJ. Assessment of microvascular leakage
via sputum induction: the role of substance P and neurokinin A in patients with asthma.
Am J Respir Crit Care Med 2002;165:1275-79.
104. Harrison NK, Dawes KE, Kwon OJ, Barnes PJ, Laurent GJ, Chung KF. Effects of
neuropeptides on human lung fibroblast proliferation and chemotaxis. Am J Physiol
1995;12:L278-83.
105. Noveral JP, Grunstein MM. Tachykinin regulation of airway smooth muscle cell prolif-
eration. Am J Physiol 1995;269:L339-43.
106. Kim JS, Rabe KF, Magnussen H, Green JM, White RS. Migration and proliferation of
guinea pig and human airway epithelial cells in response to tachykinins. Am J Physiol
1995;269:L119-26.
107. Ziche M, Morbidelli L, Geppetti P, Maggi CA, Dolara P. Substance P induces migration
of capillary endothelial cells: a novel NK-1 selective receptor mediated activity. Life Sci
1991;48:L7-11.
108. Ziche M, Morbidelli L, Pacini M, Dolara P, Maggi CA. NK1-receptors mediate the
proliferative response of human fibroblasts to tachykinins. Br J Pharmacol 1990;
100:11-14.
109. Ziche M, Parenti A, Amerini S, Zawieja D, Maggi CA, Ledda F. Effect of the non-
peptide blocker (/-) CP 96,345 on the cellular mechanism involved in the response to
NK1 receptor stimulation in human skin fibroblasts. Neuropeptides 1996;30:345-54.
110. White SR, Garland A, Gitter B, Rodger I, Alger LE, Necheles J, et al. Proliferation of
guinea pig tracheal epithelial cells in coculture with rat dorsal root ganglion neural cells.
Am J Physiol 1995;268:L957-65.
111. Wiedermann CJ, Auer B, Sitte B, Reinisch N, Schratzberger P, Kahler CM. Induction
of endothelial cell differentiation into capillary-like structures by substance P. Eur J
Pharmacol 1996;298:335-38.
112. Joos GF, Germonpre PR, Pauwels RA. Role of tachykinins in asthma. Allergy
2000;55:321-37.
113. Joos GF, Pauwels RA. Pro-inflammatory effects of substance P: new perspectives for the
treatment of airway diseases? Trends Pharmacol Sci 2000;21:131-33.
114. Snider RM, Constantine JW, Lowe JA III, Longo KP, Lebel WS, Woody HA, et al.
A potent nonpeptide antagonist of the substance P (NK1) receptor. Science 1991;251:
435-37.
115. Emonds-Alt X, Vilain P, Goulaouic P, Proietto V, Van Broeck D, Advenier C, et al. A
potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. Life Sci
1992;50:L101-6.
116. Bertrand C, Geppetti P, Graf PD, Foresi A, Nadel JA. Involvement of neurogenic
inflammation in antigen-induced bronchoconstriction in guinea pigs. Am J Physiol
1993;265:L507-11.
117. Bertrand C, Geppetti P, Baker J, Yamawaki I, Nadel JA. Role of neurogenic inflam-
mation in antigen-induced vascular extravasation in guinea pig trachea. J Immunol
1993;150:1479-85.
118. Kudlacz EM, Knippenberg RW, Logan DE, Burkholder TP. Effect of MDL 105,212, a
nonpeptide NK-1/NK-2 receptor antagonist in an allergic guinea pig model. J Pharmacol
Exp Ther 1996;279:732-39.
